Home
Gilead Sciences GILD paid Forbes-Tate $90K for lobbying in Q2 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $90,000
- Quarter
- Q2 2026
- Stock
- Gilead Sciences GILD
- Client
- Gilead Sciences
- Reported
- 26/07/20
Up 0.0% from last quarter
What else happened in Gilead Sciences around then
Filed or reported within 30 days of the trade day · 05/31~07/30Gilead Sciences's other lobbying reports
- Gilead Sciences
LobbyingGilead Sciences
LobbyingGilead Sciences
GILD
$80K
$80K
Reported 07/20
for Q2
- Gilead Sciences
LobbyingGilead Sciences
LobbyingGilead Sciences
GILD
$80K
$80K
Reported 07/20
for Q2
- Gilead Sciences
LobbyingGilead Sciences
LobbyingGilead Sciences
GILD
$1.6M
$1.6M
Reported 07/20
for Q2
- Gilead Sciences
LobbyingGilead Sciences
LobbyingGilead Sciences
GILD
$60K
$60K
Reported 07/20
for Q2
- Gilead Sciences
LobbyingGilead Sciences
LobbyingGilead Sciences
GILD
$75K
$75K
Reported 07/20
for Q2